Produkt | Reakt. | Katalog # | CE-IVD/RUO | Methode | |
---|---|---|---|---|---|
HPV | |||||
HPV 14 Screening & 16, 14, 45 Typing Real-TM Quant | 100 | AMP 200-V31-100/F FRT | CE-IVD | RT-PCR | |
HPV High Risk Screen Real-TM 2x Quant (2 Channels) | 100 | AMP 200-TV31-100/2FRT 2X | CE-IVD | RT-PCR | |
HPV High Risk Screen Real-TM 2x Quant (2 Channels) | 100 | AMP 200-V31-100/2FRT 2X | CE-IVD | RT-PCR | |
HPV High Risk Screen Real-TM Quant | 100 | AMP 200-V31-100/2FRT | CE-IVD | RT-PCR | |
HPV High Risk Screen | 110 | AMP 200-V-26-100F | CE-IVD | Agarose | |
HPV genotypes 14 Real-TM Quant | 100 | AMP 200-V67-100FRT | CE-IVD | RT-PCR | |
HPV 16/18 Real-TM Quant | 100 | AMP 200-TV12-100FRT | CE-IVD | RT-PCR | |
HPV 16/18 Real-TM Quant | 100 | AMP 200-V12-100FRT | CE-IVD | RT-PCR | |
HPV High Risk Typing | 55 | AMP 200-V-25-50F | CE-IVD | Agarose | |
HPV 6/11 Real-TM | 100 | AMP 200-TV11-100FRT | CE-IVD | RT-PCR | |
HPV 6/11 Real-TM | 100 | AMP 200-V11-100FRT | CE-IVD | RT-PCR | |
HPV 6/11 | 55 | AMP 200-V-135-100F | CE-IVD | Agarose | |
HPV 14 Screening & 16, 14, 45 Typing Real-TM Quant | 100 | AMP 200-V31-100/F FRT | CE-IVD | RT-PCR | |
HPV High Risk Screen Real-TM 2x Quant (2 Channels) | 100 | AMP 200-TV31-100/2FRT 2X | CE-IVD | RT-PCR | |
HPV High Risk Screen Real-TM 2x Quant (2 Channels) | 100 | AMP 200-V31-100/2FRT 2X | CE-IVD | RT-PCR | |
HPV High Risk Screen Real-TM Quant | 100 | AMP 200-V31-100/2FRT | CE-IVD | RT-PCR | |
HPV High Risk Screen | 110 | AMP 200-V-26-100F | CE-IVD | Agarose | |
HPV genotypes 14 Real-TM Quant | 100 | AMP 200-V67-100FRT | CE-IVD | RT-PCR | |
HPV 16/18 Real-TM Quant | 100 | AMP 200-TV12-100FRT | CE-IVD | RT-PCR | |
HPV 16/18 Real-TM Quant | 100 | AMP 200-V12-100FRT | CE-IVD | RT-PCR | |
HPV High Risk Typing | 55 | AMP 200-V-25-50F | CE-IVD | Agarose | |
HPV 6/11 Real-TM | 100 | AMP 200-TV11-100FRT | CE-IVD | RT-PCR | |
HPV 6/11 Real-TM | 100 | AMP 200-V11-100FRT | CE-IVD | RT-PCR | |
HPV 6/11 | 55 | AMP 200-V-135-100F | CE-IVD | Agarose |